CP-866087 - An Overview
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, lowered flavin or flavoprotein as a person donor, and incorporation of 1 atom of oxygenlenacapavir will enhance the amount or impact of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.This website is using